Showing results (491-500 of 507) with videos related to

Sort By:
Pageof 51
Cell|September 23, 2017
A Human Bi-specific Antibody against Zika Virus with High Therapeutic PotentialJiaqi Wang, Marco Bardelli, Diego A Espinosa, et al.
Alzheimer'S Research & Therapy|August 18, 2021
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohortG Ortega, A Espinosa, M Alegret, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research ProtocolsO Rodriguez-Gomez, A Sanabria, A Perez-Cordon, et al.
Alzheimer'S Research & Therapy|December 1, 2018
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)Itziar de Rojas, J Romero, O Rodríguez-Gomez, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Frontiers in Bioengineering and Biotechnology|December 5, 2023
Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigensTammy Boggiano-Ayo, Julio Palacios-Oliva, Sumlai Lozada-Chang, et al.
Molecular Psychiatry|July 17, 2013
ATP5H/KCTD2 locus is associated with Alzheimer's disease riskM Boada, C Antúnez, R Ramírez-Lorca, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Translational Psychiatry|February 6, 2014
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneA Ruiz, S Heilmann, T Becker, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Pageof 51